Format

Send to

Choose Destination
Expert Rev Clin Immunol. 2018 Jul;14(7):549-556. doi: 10.1080/1744666X.2018.1481750. Epub 2018 Jun 26.

Keeping it in the family: the case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disorders.

Author information

1
a Department of Virology and Immunology , Auckland City Hospital , Auckland , New Zealand.
2
b Department of Clinical Immunology , Auckland City Hospital , Auckland , New Zealand.
3
c School of Biological Sciences , University of Auckland , Auckland , New Zealand.
4
d Starship Children's Health , Auckland , New Zealand.

Abstract

Common variable immunodeficiency disorders (CVID) are the most frequent symptomatic primary immune defect in adults. Within the broad spectrum of CVID, a proportion of patients present with a predominant T cell phenotype associated with increased mortality. These patients are termed late-onset combined immunodeficiency (LOCID) and are currently separated from patients suffering from CVID. Areas covered: We have recently codiscovered a new CVID-like disorder caused by mutations of the NFKB1 gene. Members of this non-consanguineous New Zealand kindred have a very diverse spectrum of phenotypes in spite of carrying the identical mutation. The proband appears to have the autoimmune variant. The proband's recently deceased sister best matched LOCID while other family members are less severely affected, including one asymptomatic adult brother, who has an affected daughter. Differences in genetics was one of the main arguments for separating these disorders in the past. Expert commentary: Given the recent advances in the understanding of the genetic basis of these conditions, we present the case that LOCID should now be considered a subset of CVID, rather than a separate disorder. At a clinical level, this distinction is less important but it is imperative these patients are carefully evaluated, the relevant complications are treated, and they are offered prognostic information.

KEYWORDS:

CVID; CVID-like; IVIG; LOCID; NFKB1

PMID:
29806948
DOI:
10.1080/1744666X.2018.1481750
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center